Skip to main content
RE

RevOpsis Therapeutics

Springfield, United States
Last funding
Undisclosed
SeedSep 2025

RevOpsis Therapeutics employs the Surrobody platform to tackle vision loss and target diverse eye conditions with potential therapeutics.

Backed byExSight VenturesNational Eye Institute

About RevOpsis Therapeutics

Who are RevOpsis Therapeutics's investors?

RevOpsis Therapeutics's investors include ExSight Ventures, National Eye Institute.

Where is RevOpsis Therapeutics headquartered?

RevOpsis Therapeutics is headquartered in Springfield, United States.

What does RevOpsis Therapeutics do?

RevOpsis Therapeutics employs the Surrobody platform to tackle vision loss and target diverse eye conditions with potential therapeutics.

What stage is RevOpsis Therapeutics at?

RevOpsis Therapeutics is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"RevOpsis Therapeutics — Funding & Investors." VCBacked, September 16, 2025, https://www.vcbacked.co/company/revopsis-therapeutics. Accessed November 14, 2026.
APA
VCBacked. (2025). RevOpsis Therapeutics — Funding & Investors. Retrieved November 14, 2026, from https://www.vcbacked.co/company/revopsis-therapeutics
Wikipedia (cite web)
{{cite web |title=RevOpsis Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/revopsis-therapeutics |website=VCBacked |access-date=November 14, 2026}}

Profile data sourced and verified per the VCbacked methodology · Last funding round dated

Work at RevOpsis Therapeutics? Request a listing update

Founder contacts
m***@revopsis.com
linkedin.com/in/●●●●●●
Emails, phones & LinkedIn · 41,000+ verified contacts
Get instant access →